INCR logo

InterCure (INCR)

Profile

Full Name

InterCure Ltd.

Ticker Symbol

INCR

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Israel

IPO

January 28, 2019

Indexes

Not included

Website

http://www.intercure.co

Employees

270

Key Details

Price

$1.37(+3.40%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$96.62M(-16.74% YoY)

Annual EPS

-$0.37(-225.03% YoY)

PE ratio

-

Next earnings date

Aug 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.37
INCR price is $1.37

30-Day Relative Volume

0.50
INCR 30-day relative volume is 0.50

Price Performance

Price Most recent change

+3.4%
INCR price was up +3.4% on Apr 16, 2025

Price YTD change

-13.84%
INCR price is down -13.84% since January 1st

Price 1-year change

-41.95%
INCR price is down -41.95% year-on-year

Price 3-year change

-77.9%
INCR price is down -77.9% over the past 3 years

Price Range

Price All-time high

$9.99
INCR price is currently -86.29% below its historical high of $9.99

Price 3-year low

$0.99
INCR price is currently +38.38% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$64.61M
INCR market capitalization is $64.61 million

Market cap 3-year change

-76.91%
INCR market capitalization is down -76.91% over the past 3 years

Market cap All-time high

$370.10M
INCR market capitalization is currently -82.54% below its historical high of $370.10 million

Market cap sector rank

42.19%
INCR market capitalization is higher than 42.19% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.49%
INCR shares outstanding is up +3.49% year-on-year

Shares Outstanding 3-Year Change

+4.5%
INCR shares outstanding is up +4.5% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.55
INCR beta is 0.55

200-day SMA

$1.74
INCR price is currently -21.17% below its 200-day simple moving average

50-day SMA

$1.52
INCR price is currently -9.65% below its 50-day simple moving average

RSI

46.98
INCR 14-day relative strength index is 46.98

Volume

0.50
INCR 30-day relative volume is 0.50

ATR

$0.07
INCR average true range is $0.07

10-day Historical Volatility

53.15%
INCR 10-day historical volatility is 53.15%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$96.62M
INCR annual revenue is $96.62 million

Revenue Analysts estimate

$335.10M
INCR annual revenue is currently -71.17% lower than the consensus analysts' forecast

Revenue 1-year change

-16.74%
INCR annual revenue is down -16.74% year-on-year

Revenue Sector rank

55.77%
INCR annual revenue is higher than 55.77% of companies in Healthcare sector

EPS

EPS

-$0.37
INCR annual earnings per share is -$0.37

EPS Analysts estimate

-
INCR annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-225.03%
INCR annual earnings per share is down -225.03% year-on-year

EPS Sector rank

72.15%
INCR annual earnings per share is higher than 72.15% of companies in Healthcare sector

Profit

Gross profit

$28.56M
INCR annual gross profit is $28.56 million

Gross margin

29.56%
INCR annual gross profit margin is 29.56%

Operating profit

$10.22M
INCR annual operating income is $10.22 million

Operating margin

10.57%
INCR annual operating profit margin is 10.57%

Net income

-$16.84M
INCR annual net profit is -$16.84 million

Net margin

-17.43%
INCR annual net profit margin is -17.43%

Expenses

Total expenses

$86.40M
INCR annual total expenses is $86.40 million

Operating expenses

$18.34M
INCR annual total operating expenses is $18.34 million

Cost of goods sold

$68.06M
INCR annual cost of goods sold is $68.06 million

Selling, general & administrative expenses

$23.43M
INCR annual SGA is $23.43 million

Depreciation and amortization

$3.58M
INCR annual depreciation & amortization is $3.58 million

Interest expense

$6.58M
INCR annual interest expense is $6.58 million

Income tax

$610.90K
INCR annual income tax is $610.90 thousand

EBIT & EBITDA

EBIT

-$10.07M
INCR annual earnings before interest & taxes is -$10.07 million

EBITDA

-$6.49M
INCR annual EBITDA is -$6.49 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$218.63M
INCR annual total assets is $218.63 million

Non current assets

$102.23M
INCR annual long term assets is $102.23 million

Current assets

$116.40M
INCR annual total current assets is $116.40 million

Cash and cash equivalents

$28.11M
INCR annual cash & cash equivalents is $28.11 million

Accounts receivable

$16.79M
INCR annual accounts receivable is $16.79 million

Inventory

$29.54M
INCR annual inventory is $29.54 million

Liabilities

Total liabilities

$91.60M
INCR annual total liabilities is $91.60 million

Long term liabilities

$28.82M
INCR annual total long term liabilities is $28.82 million

Current liabilities

$62.78M
INCR annual total current liabilities is $62.78 million

Accounts payable

$21.80M
INCR annual accounts payable is $21.80 million

Debt

Total debt

$54.39M
INCR annual total debt is $54.39 million

Total debt 1-year change

-24.83%
INCR annual total debt is down -24.83% year-on-year

Long term debt

$28.58M
INCR annual long term debt is $28.58 million

Short term debt

$25.80M
INCR annual short term debt is $25.80 million

Equity & Capital

Shareholders equity

$126.49M
INCR annual stockholders equity is $126.49 million

Book value

$126.49M
INCR annual book value is $126.49 million

Retained earnings

-$56.70M
INCR annual retained earnings is -$56.70 million

Working capital

$53.62M
INCR annual working capital is $53.62 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$14.57M
INCR annual cash flow from operations is -$14.57 million

Cash from operations 1-year change

-195.21%
INCR annual cash flow from operations is down -195.21% year-on-year

Cash from investing

$1.30M
INCR annual cash flow from investing activities is $1.30 million

Cash from investing 1-year change

+103.05%
INCR annual cash flow from investing activities is up +103.05% year-on-year

Cash from financing

-$22.52M
INCR annual cash flow from financing activities is -$22.52 million

Cash from financing 1-year change

-162.64%
INCR annual cash flow from financing activities is down -162.64% year-on-year

CAPEX

CAPEX

$711.70K
INCR annual capital expenditures is $711.70 thousand

CAPEX 1-year change

-87.93%
INCR annual capital expenditures is down -87.93% year-on-year

Free Cash Flow

Free cash flow

-$15.29M
INCR annual free cash flow is -$15.29 million

Free cash flow 1-year change

-262.4%
INCR annual free cash flow is down -262.4% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

29.56%
INCR annual gross profit margin is 29.56%

Operating margin

10.57%
INCR annual operating profit margin is 10.57%

Net margin

-17.43%
INCR annual net profit margin is -17.43%

ROA & ROE

ROA

-6.87%
INCR annual return on assets is -6.87%

ROE

-12.25%
INCR annual return on equity is -12.25%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
INCR price to earnings ratio value is unknown

PE ratio Sector rank

-
INCR price to earnings ratio is unknown

PB Ratio

PB ratio

0.53
INCR price to book ratio is 0.53

PB ratio Sector rank

31.14%
INCR price to book ratio is higher than 31.14% of companies in Healthcare sector

PS Ratio

PS ratio

-
INCR price to sales ratio value is unknown

PS ratio Sector rank

-
INCR price to sales ratio is unknown

Enterprise value

Enterprise value

$99.39M
INCR enterprise value is $99.39 million

Enterprise value Sector rank

50.29%
INCR enterprise value is higher than 50.29% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
INCR EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
INCR EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.85
INCR annual current ratio is 1.85

Quick ratio

1.38
INCR annual quick ratio is 1.38

Leverage

Debt to equity

0.37
INCR annual debt to equity ratio is 0.37

Interest coverage ratio

-1.53
INCR annual interest coverage ratio is -1.53

Risk & Stability

Piotroski F-Score

-
INCR piotroski f-score value is unknown

Altman Z-Score

0.64
INCR altman z-score is 0.64

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

Sagimet Biosciences (SGMT)
CTSO logo
Cytosorbents (CTSO)
CPIX logo
Cumberland Pharmaceuticals (CPIX)
INO logo
Inovio Pharmaceuticals (INO)
PETS logo
PetMed Express (PETS)
YI logo
111 (YI)
ICCM logo
IceCure Medical Ltd (ICCM)
VANI logo
Vivani Medical (VANI)
CLSD logo
Clearside Biomedical (CLSD)
  • What is the ticker symbol for InterCure?
  • Does InterCure pay dividends?
  • What sector is InterCure in?
  • What industry is InterCure in?
  • What country is InterCure based in?
  • When did InterCure go public?
  • Is InterCure in the S&P 500?
  • Is InterCure in the NASDAQ 100?
  • Is InterCure in the Dow Jones?
  • When was InterCure's last earnings report?
  • When does InterCure report earnings?

What is the ticker symbol for InterCure?

The ticker symbol for InterCure is NASDAQ:INCR

Does InterCure pay dividends?

No, InterCure does not pay dividends

What sector is InterCure in?

InterCure is in the Healthcare sector

What industry is InterCure in?

InterCure is in the Drug Manufacturers - Specialty & Generic industry

What country is InterCure based in?

InterCure is headquartered in Israel

When did InterCure go public?

InterCure's initial public offering (IPO) was on January 28, 2019

Is InterCure in the S&P 500?

No, InterCure is not included in the S&P 500 index

Is InterCure in the NASDAQ 100?

No, InterCure is not included in the NASDAQ 100 index

Is InterCure in the Dow Jones?

No, InterCure is not included in the Dow Jones index

When was InterCure's last earnings report?

InterCure's most recent earnings report was on Aug 29, 2024

When does InterCure report earnings?

The next expected earnings date for InterCure is Aug 29, 2025
On this page